Literature DB >> 16886043

Normal iron metabolism and the pathophysiology of iron overload disorders.

Chiang W Siah1, John Ombiga, Leon A Adams, Debbie Trinder, John K Olynyk.   

Abstract

Iron overload disorders represent a heterogenous group of conditions resulting from inherited and acquired causes. If undiagnosed they can be progressive and fatal. Early detection and phlebotomy prior to the onset of cirrhosis can reduce morbidity and normalise life expectancy. We now have greater insight into the complex mechanisms of normal and disordered iron homeostasis following the discovery of new proteins and genetic defects. Here we review the normal mechanisms and regulation of gastrointestinal iron absorption and liver iron transport and their dysregulation in iron overload states. Advances in the understanding of the natural history of iron overload disorders and new methods for clinical detection and management of hereditary haemochromatosis are also reviewed. The current screening strategies target high-risk groups such as first-degree relatives of affected individuals and those with clinical features suggestive of iron loading. Potential ethical, legal and psychosocial issues arising through application of genetic screening programs need to be resolved prior to implementation of general population screening programs.

Entities:  

Year:  2006        PMID: 16886043      PMCID: PMC1390789     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN: 0159-8090


  122 in total

Review 1.  Screening for hemochromatosis in primary care settings.

Authors:  S M McDonnell; P D Phatak; V Felitti; A Hover; G D McLaren
Journal:  Ann Intern Med       Date:  1998-12-01       Impact factor: 25.391

2.  Haemochromatosis and HLA-H.

Authors:  E C Jazwinska; L M Cullen; F Busfield; W R Pyper; S I Webb; L W Powell; C P Morris; T P Walsh
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

3.  Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis.

Authors:  R E Fleming; M C Migas; C C Holden; A Waheed; R S Britton; S Tomatsu; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

4.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Authors:  Gaël Nicolas; Caroline Chauvet; Lydie Viatte; Jean Louis Danan; Xavier Bigard; Isabelle Devaux; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

5.  Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation.

Authors:  A Pascoe; P Kerlin; C Steadman; A Clouston; D Jones; L Powell; E Jazwinska; S Lynch; R Strong
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

6.  A population-based study of the clinical expression of the hemochromatosis gene.

Authors:  J K Olynyk; D J Cullen; S Aquilia; E Rossi; L Summerville; L W Powell
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

7.  Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons.

Authors:  A Asberg; K Hveem; K Thorstensen; E Ellekjter; K Kannelønning; U Fjøsne; T B Halvorsen; H B Smethurst; E Sagen; K S Bjerve
Journal:  Scand J Gastroenterol       Date:  2001-10       Impact factor: 2.423

8.  Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract.

Authors:  S Parkkila; A Waheed; R S Britton; J N Feder; Z Tsuchihashi; R C Schatzman; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

9.  Increased hepcidin expression and hypoferraemia associated with an acute phase response are not affected by inactivation of HFE.

Authors:  David M Frazer; Sarah J Wilkins; Kirstin N Millard; Andrew T McKie; Christopher D Vulpe; Gregory J Anderson
Journal:  Br J Haematol       Date:  2004-08       Impact factor: 6.998

10.  Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload.

Authors:  H Zoller; R O Koch; I Theurl; P Obrist; A Pietrangelo; G Montosi; D J Haile; W Vogel; G Weiss
Journal:  Gastroenterology       Date:  2001-05       Impact factor: 22.682

View more
  24 in total

1.  Different forms of iron accumulation in the liver on MRI.

Authors:  İlkay S İdilman; Deniz Akata; Mustafa Nasuh Özmen; Muşturay Karçaaltıncaba
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

2.  Medical geological study of disease-causing elements in Wassa area of Southwest Ghana.

Authors:  Emmanuel Arhin; Chaosheng Zhang; Raymond Kazapoe
Journal:  Environ Geochem Health       Date:  2019-06-22       Impact factor: 4.609

Review 3.  Pathogenesis of Nonalcoholic Steatohepatitis.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2016-02-27       Impact factor: 22.682

4.  Renal anemia: a nephrologist's view.

Authors:  G Tsagalis
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

Review 5.  An update on iron physiology.

Authors:  Manuel Muñoz; Isabel Villar; José Antonio García-Erce
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

Review 6.  Iron metabolism: from health to disease.

Authors:  Fernando Oliveira; Sara Rocha; Rúben Fernandes
Journal:  J Clin Lab Anal       Date:  2014-01-29       Impact factor: 2.352

7.  Neuroinflammation, oxidative stress, and blood-brain barrier (BBB) disruption in acute Utah electrode array implants and the effect of deferoxamine as an iron chelator on acute foreign body response.

Authors:  Cassie Bennett; Farrah Mohammed; Anabel Álvarez-Ciara; Michelle A Nguyen; W Dalton Dietrich; Suhrud M Rajguru; Wolfgang J Streit; Abhishek Prasad
Journal:  Biomaterials       Date:  2018-10-18       Impact factor: 12.479

8.  Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting.

Authors:  Toshimichi Miya; Haruhiko Kondo; Akihiko Gemma
Journal:  Int J Clin Oncol       Date:  2018-07-24       Impact factor: 3.402

Review 9.  Iron Therapy in Heart Failure: Ready for Primetime?

Authors:  Ify R Mordi; Aaron Tee; Chim C Lang
Journal:  Card Fail Rev       Date:  2018-05

10.  Analysis of HFE and non-HFE gene mutations in Brazilian patients with hemochromatosis.

Authors:  Paulo Lisboa Bittencourt; Maria Lúcia Carnevale Marin; Cláudia Alves Couto; Eduardo Luiz Rachid Cançado; Flair José Carrilho; Anna Carla Goldberg
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.